Matthew Tilton, DO
Family Medicine · Kirksville, MONPI 1356802649
Payments from drug & device makers
Across 109 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$259
- AstraZeneca$229
- Amgen$175
- Dexcom, Inc.$124
- Abbott$113
- Novo Nordisk$91
- plus $886 from 30 others
What the payments were for
- Food & beverage$1,876100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 17 | $259 |
| AstraZeneca | 10 | $229 |
| Amgen | 11 | $175 |
| Dexcom, Inc. | 6 | $124 |
| Abbott | 6 | $113 |
| Novo Nordisk | 6 | $91 |
| Pfizer | 4 | $88 |
| Bayer | 5 | $80 |
| AbbVie | 5 | $75 |
| Merck | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $56 |
| Kowa Pharmaceuticals America, Inc. | 3 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Corium, LLC | 2 | $31 |
| Ardelyx, Inc. | 2 | $30 |
| Verona Pharma, Inc. | 2 | $29 |
| Radius Health, Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $21 |
| Medtronic | 1 | $20 |
| Resmed Corp | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Novartis | 1 | $15 |
| Organon | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Sobi, Inc | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
How this compares
$1,876 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 59 | $58,578 |
| JardianceEmpagliflozin | 49 | $50,388 |
| EliquisApixaban | 47 | $36,381 |
| VraylarCariprazine Hcl | 11 | $28,038 |
| Spiriva RespimatTiotropium Bromide | 30 | $15,942 |
| EntrestoSacubitril/Valsartan | 16 | $11,824 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,819 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $10,562 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $9,652 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $8,738 |
| XareltoRivaroxaban | 12 | $6,851 |
| Atrovent HfaIpratropium Bromide | 12 | $5,866 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 11 | $2,852 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 15 | $2,686 |
| Humalog Kwikpen U-100Insulin Lispro | 19 | $2,435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $91 | $58,57859 claims |
| PfizerEliquis | $88 | $36,38147 claims |
| AbbVieVraylar, Synthroid | $75 | $28,72724 claims |
| NovartisEntresto | $15 | $11,82416 claims |
| GSKTrelegy Ellipta | $16 | $11,81918 claims |
| Sanofi-aventis U.S. LLCLantus | $23 | $78412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Kirksville
- Justin PuckettKirksville$568K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.